SS
CRL icon

Sunbelt Securities’s Charles River Laboratories CRL Stock Holding History

Sunbelt Securities’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6
Closed -$1.2K – 2983
2025
Q4 		$1.2K Hold
6
– – ﹤0.01% 2008
2025
Q3 		$939 Hold
6
– – ﹤0.01% 2074
2025
Q2 		$1.11K Hold
6
– – ﹤0.01% 1654
2025
Q1 		$903 Hold
6
– – ﹤0.01% 1657
2024
Q4 		$1.1K Hold
6
– – ﹤0.01% 1659
2024
Q3 		$1.18K Sell
6
-230
-97% -$47.8K ﹤0.01% 1664
2024
Q2 		$48.8K Sell
236
-22
-9% -$4.99K 0.01% 910
2024
Q1 		$69.9K Buy
258
+236
+1,073% +$56.4K 0.01% 798
2023
Q4 		$5.2K Hold
22
– – ﹤0.01% 1305
2023
Q3 		$4.31K Sell
22
-8
-27% -$1.64K ﹤0.01% 1340
2023
Q2 		$6.31K Buy
30
+14
+88% +$2.79K ﹤0.01% 1282
2023
Q1 		$3.17K Buy
+16
New +$3.63K ﹤0.01% 1375

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sunbelt Securities's CRL Position: Q1 2026 in Review

Sunbelt Securities sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 6 shares — an estimated $1.2K sold.

Sunbelt Securities first reported a position in CRL in Q1 2023 and held it in 12 quarters. The position peaked at $69.9K in Q1 2024. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Sunbelt Securities reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Sunbelt Securities sold 6 Charles River Laboratories shares in Q1 2026, an estimated $1.2K.
  • Sunbelt Securities first reported a position in Charles River Laboratories in Q1 2023 and held it in 12 quarters.
  • Sunbelt Securities's Charles River Laboratories position peaked at $69.9K in Q1 2024.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.